Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma
Publication year
2022Source
Nature Communications, 13, 1, (2022), article 6149ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Internal Medicine
Radiation Oncology
Haematology
Laboratory Medicine
Surgery
Medical Imaging
Pathology
Journal title
Nature Communications
Volume
vol. 13
Issue
iss. 1
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 14: Tumours of the digestive tract RIHS: Radboud Institute for Health Sciences; Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health Sciences; Radboudumc 19: Nanomedicine RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 5: Inflammatory diseases RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 9: Rare cancers RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [227696]
- Electronic publications [108794]
- Faculty of Medical Sciences [87091]
- Open Access publications [77993]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.